Stocktoria
Fresenius Medical Care AG FME.DE
Fresenius Medical Care AG (FME.DE) earns a Piotroski F-score of 8/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 3.97% (safety: moderate). FY2025 revenue was $19.6B at a 5.0% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 23 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 8/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.053 |
| Retained earnings / assets | 0.394 |
| EBIT / assets | 0.059 |
| Equity / liabilities | 0.796 |
FAQ
Is FME.DE financially healthy?
Fresenius Medical Care AG's Piotroski F-score is 8/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does FME.DE pay a dividend, and is it safe?
Yes. Fresenius Medical Care AG pays a dividend yielding about 3.97% with a 43.2% payout ratio, rated “moderate” for safety.
How profitable is FME.DE?
In FY2025, Fresenius Medical Care AG had a net margin of 5.0% and a return on equity of 7.4%.
Source: company filings via Yahoo Finance · DE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.